Literature DB >> 21235353

Occludin protein family: oxidative stress and reducing conditions.

Ingolf E Blasig1, Christian Bellmann, Jimmi Cording, Giovanna Del Vecchio, Denise Zwanziger, Otmar Huber, Reiner F Haseloff.   

Abstract

The occludin-like proteins belong to a family of tetraspan transmembrane proteins carrying a marvel domain. The intrinsic function of the occludin family is not yet clear. Occludin is a unique marker of any tight junction and is found in polarized endothelial and epithelial tissue barriers, at least in the adult vertebrate organism. Occludin is able to oligomerize and to form tight junction strands by homologous and heterologous interactions, but has no direct tightening function. Its oligomerization is affected by pro- and antioxidative agents or processes. Phosphorylation of occludin has been described at multiple sites and is proposed to play a regulatory role in tight junction assembly and maintenance and, hence, to influence tissue barrier characteristics. Redox-dependent signal transduction mechanisms are among the pathways modulating occludin phosphorylation and function. This review discusses the novel concept that occludin plays a key role in the redox regulation of tight junctions, which has a major impact in pathologies related to oxidative stress and corresponding pharmacologic interventions.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21235353     DOI: 10.1089/ars.2010.3542

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  46 in total

1.  Occludin regulates glucose uptake and ATP production in pericytes by influencing AMP-activated protein kinase activity.

Authors:  Victor Castro; Marta Skowronska; Jorge Lombardi; Jane He; Neil Seth; Martina Velichkovska; Michal Toborek
Journal:  J Cereb Blood Flow Metab       Date:  2017-07-18       Impact factor: 6.200

Review 2.  Blood-brain barrier integrity and glial support: mechanisms that can be targeted for novel therapeutic approaches in stroke.

Authors:  Patrick T Ronaldson; Thomas P Davis
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

3.  Cellular polarity in aging: role of redox regulation and nutrition.

Authors:  Helena Soares; H Susana Marinho; Carla Real; Fernando Antunes
Journal:  Genes Nutr       Date:  2013-12-04       Impact factor: 5.523

Review 4.  Claudins: control of barrier function and regulation in response to oxidant stress.

Authors:  Christian E Overgaard; Brandy L Daugherty; Leslie A Mitchell; Michael Koval
Journal:  Antioxid Redox Signal       Date:  2011-05-09       Impact factor: 8.401

Review 5.  Claudins and the modulation of tight junction permeability.

Authors:  Dorothee Günzel; Alan S L Yu
Journal:  Physiol Rev       Date:  2013-04       Impact factor: 37.312

Review 6.  Breaking barriers. New insights into airway epithelial barrier function in health and disease.

Authors:  Fariba Rezaee; Steve N Georas
Journal:  Am J Respir Cell Mol Biol       Date:  2014-05       Impact factor: 6.914

7.  Tight junction proteins at the blood-brain barrier: far more than claudin-5.

Authors:  Philipp Berndt; Lars Winkler; Jimmi Cording; Olga Breitkreuz-Korff; André Rex; Sophie Dithmer; Valentina Rausch; Rosel Blasig; Matthias Richter; Anje Sporbert; Hartwig Wolburg; Ingolf E Blasig; Reiner F Haseloff
Journal:  Cell Mol Life Sci       Date:  2019-02-07       Impact factor: 9.261

Review 8.  Tight junction modulation of the blood brain barrier: CNS delivery of small molecules.

Authors:  Chris Greene; Matthew Campbell
Journal:  Tissue Barriers       Date:  2016-01-08

9.  Exosomes containing miR-122-5p secreted by LPS-induced neutrophils regulate the apoptosis and permeability of brain microvascular endothelial cells by targeting OCLN.

Authors:  Qingfeng Li; Anna Nong; Zhijing Huang; Yun'an Xu; Kebin He; Yuying Jia; Yueyan Huang
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

Review 10.  The blood-testis barrier and its implications for male contraception.

Authors:  C Yan Cheng; Dolores D Mruk
Journal:  Pharmacol Rev       Date:  2011-10-28       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.